• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • FDA halts Bellicum trial over brain disease in participants, shares crash 48% pharmafile
    February 02, 2018
    Texas-based clinical-stage company Bellicum Pharmaceuticals has taken a massive stock hit after the FDA put a hold on its trials of its T-cell therapy BPX-501 due to three cases of encephalopathy in participants that are thought to be treatment-related.
  • NHL Veterans Pledge Their Brains to Research drugs.com
    February 24, 2017
    Several former National Hockey League players have joined the growing number of pro athletes who have pledged their brains to research on chronic traumatic encephalopathy (CTE) -- a devastating brain disease that has been linked to repetitive head trauma.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service